SCHEMBL7873382

SCHEMBL7873382

CNC(N)=NC(=O)c1cc2c(Cl)cc(Oc3cc(CN)ccn3)cc2[nH]1

nearest known ligand 0.42

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 20/20 0.42
LOX P28300 17/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7877855 0.91 LOXL2 (0.33) LOXL2LOX
SCHEMBL7882284 0.89 LOXL2 (0.32) LOXL2LOX
SCHEMBL7877718 0.89 RHEB (0.32)
SCHEMBL7880060 0.88 CHEK1 (0.36)
SCHEMBL7881902 0.85 LOXL2 (0.46) LOXL2LOX
SCHEMBL7877766 0.85 DHODH (0.36)
SCHEMBL7879412 0.85 RHEB (0.39)
SCHEMBL7880854 0.84 PPARG (0.40) LOXL2LOX
SCHEMBL7881815 0.84 LGALS8 (0.33)
Hydrochloric Acid SCHEMBL7881148 0.84 RHEB (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed